ACT

NOVEMBER 12/2019

news roundup

Sponsors Struggle with Trial Disclosure, Patient Privacy Requirements

An upcoming public workshop, sponsored by the National Academies of Sciences, Engineering, and Medicine, plans to take a broad look at the successes and failures in data sharing and reuse by public and private researchers, as well as perspectives of trial participants, patient organizations, and sponsors.


Clinerion Partners with PPC

PPC will use Clinerion’s Patient Network Explorer platform for clinical trials at hospitals in Korea, China and Taiwan.


advertisement

Anti-Microbial Resistance and the Role of Vaccines
Europe: Thursday, November 14, 2019 at 3pm GMT | 4pm CET
North America: Thursday, November 21, 2019 at 11am EST | 10am CST | 8am PST
Register Now



In this edition

Please Take Our Salary Survey!
The Case for Diverse Populations in the Study of Dementia
Clinerion Partners with PPC


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »



ClinOne’s eConsent with Video Capabilities Launched at Boston Children’s Hospital

Boston Children’s Hospital launched ClinOne’s eConsent with Video eConsent technology within its Pulmonary Research Team, as its first rollout. ClinOne’s Video Consent allows all parties in the informed consent process to participate from anywhere, with the goal of reducing the barriers of on-site consenting, or delays between updated consent documents and the need for re-consent.


News Notes

Quick hit list of news from wire reports including Parexel and SCRS, DCRI’s statin study award, the finalization of Medidata’s acquisition by Dassault systems, and more.


advertisement

Trends and Insights for Your Oncology Trial Tuesday, November 12, 2019 at 10am EST
Register Now


Articles

New FDA Model Aims to Speed More Rare Disease Treatments to Patients

FDA has launched the Rare Disease Cures Accelerator (RDCA) initiative within CDER to provide the infrastructure for a cooperative approach to designing and conducting clinical trials in rare diseases to improve testing, protocols, and patient enrollment in clinical trials. FDA is collaborating with the Critical Path Institute, NORD, patient groups, industry and other stakeholders on a framework for conducting more standardized rare disease natural history studies to help target treatment and design appropriate clinical trials.

advertisement

Launching Medical Devices in the Japanese Market
How to navigate regulatory and reimbursement approval

On Demand


Please Take Our Salary Survey!


Events

Risk-Based Trial Management and Monitoring
Clinical Trial Legal and Contracting Forum
Clinical Trial Financial Management
Search Upcoming Events

advertisement

Will Decentralized Clinical Trials Compound Patient and Data Quality Risks?

On Demand


Blog Posts

The Case for Diverse Populations in the Study of Dementia

Researchers will attempt the largest brain health study—the ASSIST Study—to gather data from at least 400,000 individuals, with an emphasis on diversity, for three years. The hope is by examining a larger and more diverse population, researchers will identify how a wide range of factors influence the risk of developing dementia.


advertisement

Transforming Regulatory Affairs: Sharing Industry Peer Perspectives
On Demand


Clinical Trial Insights into PTSD, Fibromyalgia

In this article, Seth Lederman, CEO of Tonix Pharmaceuticals, discusses Tonix’s diverse research and development pipeline—including potential therapies for post-traumatic stress disorder (PTSD), fibromyalgia, and cocaine intoxication.

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
LHenderson@mmhgroup.com

Advertise

Todd Baker
Group Publisher
TBaker@mmhgroup.com